Results 241 to 250 of about 5,082,152 (344)

Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks

open access: yesAnnals of Neurology, EarlyView.
Objective The objective of this study was to evaluate the timing of change of Alzheimer's disease (AD) plasma biomarkers (Aβ42/Aβ40, p‐tau217, p‐tau181, GFAP, and NfL) from six different assay platforms, alongside established AD biomarkers, using amyloid and tau positron emission tomography (PET)‐based AD progression timelines.
Marta Milà‐Alomà   +27 more
wiley   +1 more source

Walking blood bank: a plan to ensure self-sufficiency in an era of blood shortage. [PDF]

open access: yesTrauma Surg Acute Care Open
Brigmon EP   +9 more
europepmc   +1 more source

Blood α‐Synuclein Separates Parkinson's Disease from Dementia with Lewy Bodies

open access: yesAnnals of Neurology, EarlyView.
Objective Aggregation of misfolded α‐synuclein (aSyn) within the brain is the pathologic hallmark of Lewy body diseases (LBDs), including Parkinson's disease (PD), and dementia with Lewy bodies (DLB) disease. Although evidence exists for aSyn “strains,” conformations with distinct biological properties, biomarkers for PD versus DLB are lacking.
George T. Kannarkat   +17 more
wiley   +1 more source

Erratum to: Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism

open access: yesCritical Care, 2017
Pär Ingemar Johansson   +2 more
doaj   +1 more source

Transfusion transmitted infections among blood donors of Kamenge Teaching Hospital blood bank in Burundi. [PDF]

open access: yesAfr Health Sci
Ntawuyamara E   +5 more
europepmc   +1 more source

Study of Hemolysis During Storage of Blood in the Blood Bank of a Tertiary Health Care Centre

open access: yesIndian Journal of Hematology and Blood Transfusion, 2017
S. Arif, N. Yadav, S. Rehman, G. Mehdi
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy